Delivery Order SPE2DB22D2108-SPE2DB25FU5UL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $47,517.99, represents a non-competitive, non-set-aside award with an ultimate completion date of September 9, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $7,103.78 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 500 units, with a contract ceiling value of approximately $8,000. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on August 21, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,505.19 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This competitively awarded, firm fixed-price contract is non-set-aside and was executed on July 30, 2025, with an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,178.58 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a routine pharmaceutical procurement from the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,639.37 on August 14, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 500. This firm fixed-price, competitively awarded contract is scheduled for ultimate completion on August 15, 2025, with performance conducted at the vendor's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating the award was made through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Chloride Extended-Release 10 MEQ capsules (500-count containers) under a firm fixed-price contract with a ceiling value of $1,544.08. This is a non-set-aside competitive award with an ultimate completion date of August 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for potassium chloride extended-release 8 milliequivalent tablets (500 count) on August 22, 2025, with a ceiling value of $1,543.91 and an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 milliequivalent tablets in quantities of 500 units. This firm fixed price delivery order, valued at $6,588.65, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement supporting global pharmaceutical procurement for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Potassium Chloride Extended-Release 10 MEQ capsules (500 count) valued at $1,024.41, with completion scheduled for August 1, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5ULDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with a ceiling value of $1,754.24. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 12, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to the federal government's defense and healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including vaccines, branded and generic medications, and specialized medical commodities. AmerisourceBergen Drug Corp's consistent receipt of competitive, non-set-aside awards across its portfolio demonstrates its capability to meet federal procurement requirements for critical medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/11/25 |